The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-phenyl-propyl]-amide ID: ALA2370030
PubChem CID: 73351544
Max Phase: Preclinical
Molecular Formula: C17H24N4O3
Molecular Weight: 332.40
Molecule Type: Protein
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)CNC(=O)[C@H](CCc1ccccc1)NC(=O)[C@H]1CCCN1
Standard InChI: InChI=1S/C17H24N4O3/c18-15(22)11-20-16(23)14(9-8-12-5-2-1-3-6-12)21-17(24)13-7-4-10-19-13/h1-3,5-6,13-14,19H,4,7-11H2,(H2,18,22)(H,20,23)(H,21,24)/t13-,14+/m1/s1
Standard InChI Key: RUUGHIGMBFKHMT-KGLIPLIRSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
4.4144 -0.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1141 0.3581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5383 0.4081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8387 -0.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2712 0.0208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6997 0.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9485 -0.0417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6898 0.3206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4394 -0.8995 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5133 1.2327 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7247 -0.7538 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8720 -0.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9751 0.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3993 0.4997 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1723 -1.2868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1973 -2.1114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3780 0.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5774 1.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4977 -2.5404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9219 -2.4904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7653 1.2826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9511 -3.3150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5227 -3.3650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2515 -3.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 1 0
4 2 1 0
5 3 1 0
6 13 1 0
7 8 1 0
8 1 1 6
9 1 2 0
10 3 2 0
11 6 2 0
4 12 1 6
13 5 1 0
14 6 1 0
15 12 1 0
16 15 1 0
17 7 1 0
18 8 1 0
19 16 2 0
20 16 1 0
21 18 1 0
22 20 2 0
23 19 1 0
24 22 1 0
21 17 1 0
23 24 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 332.40Molecular Weight (Monoisotopic): 332.1848AlogP: -0.54#Rotatable Bonds: 8Polar Surface Area: 113.32Molecular Species: BASEHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.41CX Basic pKa: 9.50CX LogP: -0.44CX LogD: -2.52Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.51Np Likeness Score: -0.31
References 1. Johnson RL, Bontems RJ, Yang KE, Mishra RK.. (1990) Synthesis and biological evaluation of analogues of Pro-Leu-Gly-NH2 modified at the leucyl residue., 33 (6): [PMID:1971310 ] [10.1021/jm00168a045 ]